Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Education

Biotechnology

Shoreline Biosciences

Kleanthis G. Xanthopoulos

Krishna Patel

Mauro P. Avanzi

Paschalis Sideras

Charles Calderaro III

Robert Hollingsworth

Scott Forrest

Steven Neben

Vanessa Jacoby

The Scientific Research team at Shoreline Biosciences employs advanced iPSC differentiation methods and genetic programming techniques to enhance the IL-15/CISH pathway, aiming to improve the metabolic fitness, persistence, and anti-cancer activity of engineered NK cells. This multidisciplinary team of scientists and engineers focuses on pioneering research and development to advance Shoreline's cell therapy technology platform.

Scientific Research

Leadership Team

Advisory Team

Scientific Research

About

Team members

Other teams at Shoreline Biosciences

Leadership Team

Advisory Team